College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China.
Traditional Chinese Medicine Department, Chenzhou First People's Hospital, Chenzhou, China.
J Cardiovasc Pharmacol. 2022 Jun 1;79(6):759-768. doi: 10.1097/FJC.0000000000001247.
Mitochondrial transplantation (MT) refers to the process of introducing isolated mitochondria into a damaged area of the heart or other organs. In the past decade, this technique has been continuously updated as the fundamental research on the repair of damaged cells or tissues. In particular, in the field of heart protection from ischemia-reperfusion injury, the MT therapy has been developed to the clinical trial stage. Generally speaking, the goal of therapeutic intervention is to replace damaged mitochondria or increase the transfer of mitochondria between cells so as to improve mitochondrial dysfunction. In this review, we summarized the studies on MT conducted at different time nodes and outlined a range of different methods for delivering mitochondria into the target site. Finally, we described the applications of MT in different diseases and discussed the clinical studies of human MT currently in progress and the problems that need to be overcome. We hope to provide new ideas for the treatment of mitochondrial defect-related diseases.
线粒体移植(MT)是指将分离的线粒体引入心脏或其他器官受损区域的过程。在过去的十年中,随着对受损细胞或组织修复的基础研究不断更新,这项技术也在不断发展。特别是在心脏保护免受缺血再灌注损伤的领域,MT 治疗已经发展到临床试验阶段。一般来说,治疗干预的目标是替换受损的线粒体或增加线粒体在细胞间的转移,以改善线粒体功能障碍。在这篇综述中,我们总结了不同时间节点的 MT 研究,并概述了一系列将线粒体递送到靶位的不同方法。最后,我们描述了 MT 在不同疾病中的应用,并讨论了目前正在进行的人类 MT 临床研究和需要克服的问题。我们希望为治疗与线粒体缺陷相关的疾病提供新的思路。